Investment in research has significantly improved survival rates for other cancers in the past several decades. With your support, Free to Breathe is working to make lung cancer a part of this story. That's why research is a critical part of our vision to double lung cancer survival by 2022.
Lung cancer claims more lives each year than breast, colon and prostate cancer combined, but these cancers receive proportionately more research funding than lung cancer.
Since 2005, Free to Breathe has awarded more than $4 million for cutting-edge research that is essential to helping patients live longer and better lives.
Free to Breathe is currently sponsoring Young Investigator Research Grants, which provide scientists the critical ground-level support they need to build their ideas, secure further funding and advance their research. These researchers are fueling innovative ideas across a wide variety of lung cancer research areas that have long been underfunded, including:
Free to Breathe also funds the Impact Award, in partnership with Uniting Against Lung Cancer, which is expected to produce significant improvement for patients in the next five years.
@2014 Free To Breathe | All rights reserved.